Related references
Note: Only part of the references are listed.Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer
Jae Hong No et al.
GYNECOLOGIC ONCOLOGY (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray
Li Xiao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer
Abdulkader Albasri et al.
JOURNAL OF PATHOLOGY (2009)
Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer
Hung Huynh et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma
Beata Herberger et al.
CLINICAL CANCER RESEARCH (2007)
4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis
Federico Rojo et al.
CLINICAL CANCER RESEARCH (2007)
Dissecting the Akt/Mammalian target of rapamycin signaling network: Emerging results from the head and neck cancer tissue array initiative
Alfredo A. Molinolo et al.
CLINICAL CANCER RESEARCH (2007)
Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function
Katarzyna Jastrzebski et al.
GROWTH FACTORS (2007)
Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer
Josep Castellvi et al.
CANCER (2006)
A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1
RA Bachmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
eIF4E - from translation to transformation
Y Mamane et al.
ONCOGENE (2004)
Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth
M Lynch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas
CY Hsu et al.
CLINICAL CANCER RESEARCH (2004)
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth
DA Altomare et al.
ONCOGENE (2004)
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group
S Camilleri-Broet et al.
ANNALS OF ONCOLOGY (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
Share Paper
